Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

By sjmartinez • April 11, 2023

Pavord ID, Deniz Y, Corren J, Casale TB, FitzGerald JM, Izuhara K, Daizadeh N, Ortiz B, Johnson RR, Harel S, Djandji M, Goga L, Crikelair N, Rowe PJ, Busse WW. Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1213-1220.e2. doi: 10.1016/j.jaip.2022.11.043. Epub 2022 Dec 16. PMID: 36535524.

Tags: Allergy & Immunology, asthma, Dupilumab, FEV(1), Fractional exhaled nitric oxide, Predictive biomarker, Publications, Severe exacerbations

Nicolau syndrome: A case of ischemic necrosis after subcutaneous immunotherapy

Kim J, Kaddis T, Boyle S, Gupta S, Wang V, Yusin J. Nicolau syndrome: A case of ischemic necrosis after subcutaneous immunotherapy. J Allergy Clin Immunol[...]

Welcome New DoM Faculty

Jump To: CARDIOLOGY Omid Amidi, MD Doctor of Medicine:SUNY Downstate College of Medicine, Brooklyn, NY Residency: Baylor College of Medicine, Houston, TX Fellowship: University of[...]

From Mild to Mayhem: A Life-Threatening Exacerbation of Mild Asthma

Brown K, Anderson L. From Mild to Mayhem: A Life-Threatening Exacerbation of Mild Asthma. Cureus. 2024 Sep 30;16(9):e70558. doi: 10.7759/cureus.70558. PMID: 39479137; PMCID: PMC11524714.